These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 2433425

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM, Johnson M, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
    [Abstract] [Full Text] [Related]

  • 4. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB.
    J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
    [Abstract] [Full Text] [Related]

  • 5. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
    Nash JF, Meltzer HY, Gudelsky GA.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
    [Abstract] [Full Text] [Related]

  • 6. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
    Schmidt CJ, Abbate GM, Black CK, Taylor VL.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):478-83. PubMed ID: 1978728
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA, Martello AL, Katz JL, Martello MB.
    J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470
    [Abstract] [Full Text] [Related]

  • 10. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
    Gibb JW, Stone DM, Stahl DC, Hanson GR.
    NIDA Res Monogr; 1987 May; 76():316-21. PubMed ID: 2449619
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
    Slikker W, Holson RR, Ali SF, Kolta MG, Paule MG, Scallet AC, McMillan DE, Bailey JR, Hong JS, Scalzo FM.
    Neurotoxicology; 1989 May; 10(3):529-42. PubMed ID: 2576304
    [Abstract] [Full Text] [Related]

  • 13. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW, Wing LL, Geyer MA.
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [Abstract] [Full Text] [Related]

  • 14. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G, Yeh SY, De Souza EB.
    Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449
    [Abstract] [Full Text] [Related]

  • 15. Effects of MDMA and MDA on brain serotonin neurons: evidence from neurochemical and autoradiographic studies.
    De Souza EB, Battaglia G.
    NIDA Res Monogr; 1989 Feb; 94():196-222. PubMed ID: 2575225
    [Abstract] [Full Text] [Related]

  • 16. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X, Baumann MH, Xu H, Rothman RB.
    Synapse; 2004 Sep 15; 53(4):240-8. PubMed ID: 15266556
    [Abstract] [Full Text] [Related]

  • 17. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
    Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR.
    Toxicol Appl Pharmacol; 1988 Jul 15; 94(3):448-57. PubMed ID: 2456631
    [Abstract] [Full Text] [Related]

  • 18. 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.
    Schmidt CJ, Taylor VL, Abbate GM, Nieduzak TR.
    J Pharmacol Exp Ther; 1991 Jan 15; 256(1):230-5. PubMed ID: 1899117
    [Abstract] [Full Text] [Related]

  • 19. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V, O'shea E, Saadat KS, Elliott JM, Colado MI, Green AR.
    J Psychopharmacol; 2004 Sep 15; 18(3):412-6. PubMed ID: 15358986
    [Abstract] [Full Text] [Related]

  • 20. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.
    Scanzello CR, Hatzidimitriou G, Martello AL, Katz JL, Ricaurte GA.
    J Pharmacol Exp Ther; 1993 Mar 15; 264(3):1484-91. PubMed ID: 7680719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.